Lentinan alleviates sciatic nerve injury by promoting autophagy to remove myelin fragments
Phytotherapy Research · 2023
DOI: 10.1002/ptr.7862 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2023. Verfasst von Haili Xiao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Myelin Sheath, Peripheral Nerve Injuries. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangxi Province, China, Key Laboratory of Traditional Chinese Medicine of Jiangxi Province, China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Lentinan, a natural drug with wide‐ranging pharmacological activities, can regulate autophagy—the process through which Schwann cells (SCs) eliminate myelin fragments after peripheral nerve injury (PNI). However, the effect of lentinan after PNI and the role of accelerated myelin debris removal via autophagy in this process are unclear. This study examined the effect of lentinan on rat sciatic nerve repair following crush injury and the underlying mechanisms. After the successful establishment of the sciatic nerve compression injury model, group‐specific treatments were performed. The treatment group received 20 mg/kg lentinan via intraperitoneal injection, while the model group was treated with normal saline. The recovery in each group was then evaluated. Further, a rat SC line (RSC96) was cultured in medium with/without lentinan after supplementation with homogenous myelin fractions to evaluate the removal of myelin particles. Our results showed that lentinan promotes autophagic flux in vivo via the AMPK/mTOR signaling pathway, accelerates the clearance of myelin debris by SCs, and inhibits neuronal apoptosis, thereby promoting neurological recovery. Similarly, in vitro experiments showed that lentinan promotes the phagocytosis of myelin debris by SCs. In conclusion, our results suggest that lentinan primarily promotes nerve regeneration by accelerating the autophagic clearance of myelin debris in SCs, and this process is likely regulated by the AMPK/mTOR signaling pathway. Therefore, this study provides compelling evidence that lentinan may be a cost‐effective and natural treatment agent for PNI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rehabilitation Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
- Department of Hepatobiliary surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
- Institute of Translational Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
- Department of Orthopedics, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
ORCID-Profile: Jun Luo
Förderung
- Natural Science Foundation of Jiangxi Province, China
- Key Laboratory of Traditional Chinese Medicine of Jiangxi Province, China
- National Key Research and Development Program of China
- Project of the Science and Technology Department of Jiangxi Province, China
- Regional Funds of the National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Xiao, H., Wei, C., Liu, H., Li, Z., Zheng, C., & Luo, J. (2023). Lentinan alleviates sciatic nerve injury by promoting autophagy to remove myelin fragments. Phytotherapy Research. https://doi.org/10.1002/ptr.7862
Vancouver
Xiao H, Wei C, Liu H, Li Z, Zheng C, Luo J. Lentinan alleviates sciatic nerve injury by promoting autophagy to remove myelin fragments. Phytotherapy Research. 2023. doi:10.1002/ptr.7862
BibTeX
@article{Xiao2023,
author = {Xiao, Haili and Wei, Chao and Liu, Huiying and Li, Zhiqiang and Zheng, Cihua and Luo, Jun},
title = {Lentinan alleviates sciatic nerve injury by promoting autophagy to remove myelin fragments},
journal = {Phytotherapy Research},
year = {2023},
doi = {10.1002/ptr.7862}
}
EUVIMED